Lay opinion vs evidence: FTO Männer

Lay opinion often portrays FTO as a 'fat gene' that predestines men to obesity. The evidence tells a more nuanced story. FTO variants (e.g., rs9939609) are among the most robust GWAS hits for BMI, but the effect size is modest – typically 1–3 kg body weight difference between risk and non-risk carriers. The mechanism involves increased appetite and altered ghrelin signaling, not a fundamentally slow metabolism. Importantly, the effect is polygenic and heavily modified by lifestyle: physical activity, especially endurance exercise, can attenuate the FTO risk. The risk allele frequency is ~40 % in Europeans, meaning many men carry it without being overweight. Lay narratives overstate determinism. A DNA test for FTO alone has negligible predictive value; it may serve as lifestyle motivation but not as a clinical tool. Evidence strength: GWAS-validated, but effect size is small. Safety note: Not diagnostic; consult a physician for weight management.